Quantitative and qualitative MRI evaluation of cerebral small vessel disease in an elderly population: a longitudinal study

Abstract

Background

Cerebral white matter hyperintensities (WMHs), lacunes, and microbleeds are seen on magnetic resonance imaging (MRI) in small vessel disease (SVD).

Purpose

To assess SVD on MRI and its evolution over five years in an elderly population and to investigate whether relative cerebral blood flow (rCBF) at baseline was related to the progression of white matter (WM) lesions.

Material and Methods

In a population-based study, 406 participants aged 75 years underwent morphological MRI of the brain and 252 of them again at age 80 years. At age 75 years, a perfusion scan was also done. WMHs were evaluated qualitatively (visual scoring) and quantitatively (CASCADE software). Lacunes and microbleeds were counted.

Results

A significant progression of the WMH score and WMH volume occurred over five years (P < 0.0001). New lacunes were seen in 10%. Participants with new lacunes at age 80 years showed a more pronounced increase in WMHs (P < 0.0001). Microbleeds were present in 14% at age 75 years. The visual WMH score was significantly associated with the presence of microbleeds (P < 0.0001). There was no relationship between total WM rCBF and WMH volume at age 75 years, and no significant associations between regional or total rCBF at age 75 years and changes in WMH volume over five years. The total WM and GM volume decreased significantly between the ages of 75 and 80 years (P < 0.0001).

Conclusion

MRI manifestations of SVD progressed over five years in an elderly population (age range = 75–80 years). rCBF was not associated with WMH volume or progression of WMH volume.

Keywords

Cerebral small vessel disease magnetic resonance imaging (MRI)perfusion white matter brain

Get full access to this article

View all access options for this article.

References

Wardlaw

Smith

Dichgans

. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol 2013; 12: 483–497.

van der Veen

Muller

Vincken

et al.

Longitudinal relationship between cerebral small-vessel disease and cerebral blood flow: the second manifestations of arterial disease-magnetic resonance study. Stroke 2015; 46: 1233–1238.

Pantoni

. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010; 9: 689–701.

Wardlaw

Smith

Biessels

et al.

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013; 12: 822–838.

Wardlaw

Lewis

Keir

et al.

Cerebral microbleeds are associated with lacunar stroke defined clinically and radiologically, independently of white matter lesions. Stroke 2006; 37: 2633–2636.

Marstrand

Garde

Rostrup

et al.

Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities. Stroke 2002; 33: 972–976.

Shi

Thrippleton

Makin

et al.

Cerebral blood flow in small vessel disease: A systematic review and meta-analysis. J Cereb Blood Flow Metab 2016; 36: 1653–1667.

Helenius

Perkio

Soinne

et al.

Cerebral hemodynamics in a healthy population measured by dynamic susceptibility contrast MR imaging. Acta Radiol 2003; 44: 538–546.

Pantoni

Fierini

Poggesi

et al.

Impact of cerebral white matter changes on functionality in older adults: An overview of the LADIS Study results and future directions. Geriatr Gerontol Int 2015; 15(Suppl 1): 10–16.

10.

Sachdev

Wen

Chen

et al.

Progression of white matter hyperintensities in elderly individuals over 3 years. Neurology 2007; 68: 214–222.

11.

Schmidt

Enzinger

Ropele

et al.

Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study. Lancet 2003; 361: 2046–2048.

12.

van Dijk

Prins

Vrooman

et al.

Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke 2008; 39: 2712–2719.

13.

Schmidt

Berghold

Jokinen

et al.

White matter lesion progression in LADIS: frequency, clinical effects, and sample size calculations. Stroke 2012; 43: 2643–2647.

14.

De Guio

Jouvent

Biessels

et al.

Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel disease. J Cereb Blood Flow Metab 2016; 36: 1319–1337.

15.

Vernooij

van der Lugt

Ikram

et al.

Total cerebral blood flow and total brain perfusion in the general population: the Rotterdam Scan Study. J Cereb Blood Flow Metab 2008; 28: 412–419.

16.

Inzitari

Pracucci

Poggesi

et al.

Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ 2009; 339: 1–9.

17.

Damangir

Manzouri

Oppedal

et al.

Multispectral MRI segmentation of age related white matter changes using a cascade of support vector machines. J Neurol Sci 2012; 322: 211–216.

18.

Damangir

Westman

Simmons

et al.

Reproducible segmentation of white matter hyperintensities using a new statistical definition. Magn reson Mater Phy 2017; 30: 227–237.

19.

Jenkinson

Beckmann

Behrens

et al.

FSL. Neuroimage 2012; 62: 782–790.

20.

Gouw

van der Flier

Fazekas

et al.

Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. Stroke 2008; 39: 1414–1420.

21.

Schmidt

Scheltens

Erkinjuntti

et al.

White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease. Neurology 2004; 63: 139–144.

22.

Moriya

Kozaki

Nagai

et al.

Attenuation of brain white matter hyperintensities after cerebral infarction. Am J Neuroradiol 2009; 30: E43–E43.

23.

Wardlaw

Valdes Hernandez

Munoz-Maniega

. What are white matter hyperintensities made of? Relevance to vascular cognitive impairment. J Am Heart Assoc 2015; 4: 1–19.

24.

Markus

Hunt

Palmer

et al.

Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: longitudinal results of the Austrian Stroke Prevention Study. Stroke 2005; 36: 1410–1414.

25.

Ferguson

Blane

Perros

et al.

Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes 2003; 52: 149–156.

26.

Nylander

Lind

Wikstrom

et al.

Relation between cardiovascular disease risk markers and brain infarcts detected by magnetic resonance imaging in an elderly population. J Stroke Cerebrovasc Dis 2015; 24: 312–318.

27.

Verhaaren

Vernooij

de Boer

et al.

High blood pressure and cerebral white matter lesion progression in the general population. Hypertension 2013; 61: 1354–1359.

28.

Pantoni

. Pathophysiology of age-related cerebral white matter changes. Cerebrovasc Dis 2002; 13(Suppl 2): 7–10.

29.

Yang

et al.

Quantitative assessment and correlation analysis of cerebral microbleed distribution and leukoaraiosis in stroke outpatients. Neurol Res 2015; 37: 403–409.

30.

O’Sullivan

Lythgoe

Pereira

et al.

Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology 2002; 59: 321–326.

31.

Hanaoka

Kimura

Aso

et al.

Relationship between white matter lesions and regional cerebral blood flow changes during longitudinal follow up in Alzheimer's disease. Geriatr Gerontol Int 2015; 16: 838–842.

32.

Brickman

Zahra

Muraskin

et al.

Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging. Psychiatry Res 2009; 172: 117–120.

33.

van Dalen

Mutsaerts

Nederveen

et al.

White matter hyperintensity volume and cerebral perfusion in older individuals with hypertension using arterial spin-labeling. Am J Neuroradiol 2016; 37: 1824–1830.

34.

van Straaten

Fazekas

Rostrup

et al.

Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke 2006; 37: 836–840.